In 2022, 567,440 patients with end-stage renal disease in Europe received renal replacement therapy (RRT), with an unadjusted prevalence of 1074 per million population. In France, the rate was 1383 ...

As our population ages and the number of individuals with complex medical conditions increases, so does the number of people who suffer with kidney function failure: end stage kidney disease (ESRD).

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, announced today new data indicating the use of Baxter’s Sharesource remote patient management ...

DEERFIELD, Ill., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, today introduced HomeAdvantage, a fully-integrated ecosystem ...

A UCLA-led team has developed a machine-learning model that can predict with a high degree of accuracy the short-term survival of dialysis patients on continuous renal replacement therapy (CRRT). The ...

Although elevated levels of urea and creatinine define the progression and severity of AKI, their accumulation parallels that of less well-characterized metabolites that mediate the toxic effects of ...

New UK economic analyses show improved patient outcomes and health system savings – including nearly £200 million in projected UK NHS savings ...

Intra-renal delivery of fenoldopam reduced risk of contrast-induced nephropathy in high-risk patients. WASHINGTON, D.C.—Targeted renal therapy (TRT) involving intrarenal administration of fenoldopam ...

Please provide your email address to receive an email when new articles are posted on . When patients face advanced kidney disease, dialysis and transplantation are usually considered the two likely ...

A pioneering clinical trial has successfully enabled three patients with end-stage kidney disease to receive previously ...

Please provide your email address to receive an email when new articles are posted on . U.S. Renal Care announced it is in the process of obtaining bamlanivimab, a monoclonal antibody therapy that has ...